LAVA Therapeutics NV
LVTXDelisted Nov 21, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840748
LAVA Therapeutics NV was delisted on Nov 21, 2025; its insiders filed their last Form 4 on Nov 17, 2025; 21 institutions reported holding it in 13F filings for Q3 2025, worth $16.1M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in LAVA Therapeutics NV as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −1 vs. Q1 2022
- Shares held
- 7.84M
- −156.2K (−2.0%) vs. Q1 2022
- Total value
- $22.8M
- −$12.4M (−35.2%) vs. Q1 2022
- New holders
- 1
- 1 more added
- Sold out
- 2
- 8 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 21 | $16.1M |
| Q2 2025 | 19 | $10.6M |
| Q1 2025 | 20 | $10.2M |
| Q4 2024 | 22 | $6.15M |
| Q3 2024 | 21 | $5.99M |
| Q2 2024 | 19 | $6.77M |
| Q1 2024 | 20 | $12.5M |
| Q4 2023 | 14 | $9.22M |
| Q3 2023 | 14 | $8.47M |
| Q2 2023 | 15 | $11.7M |
| Q1 2023 | 19 | $11.2M |
| Q4 2022 | 20 | $26.3M |
| Q3 2022 | 13 | $34.1M |
| Q2 2022 | 17 | $22.8M |
| Q1 2022 | 18 | $35.2M |
| Q4 2021 | 20 | $44.3M |
| Q3 2021 | 19 | $48.6M |
| Q2 2021 | 18 | $95.5M |
| Q1 2021 | 24 | $139.1M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding LAVA Therapeutics NV; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 48 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 406 | $1.00K | 0.00% | −820−66.9% | Reduced |
| TSFG, LLC | 400 | $1.00K | 0.00% | 00.0% | Unchanged |
| Cannell Capital LLC | 4,058 | $12.0K | 0.00% | +4,058 | New |
| Morgan Stanley | 5,700 | $17.0K | 0.00% | +2,900+103.6% | Added |
| Geode Capital Management, LLC | 11,124 | $31.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 15,173 | $45.0K | 0.00% | −2,474−14.0% | Reduced |
| Millennium Management LLC | 96,405 | $276.0K | 0.00% | −54,225−36.0% | Reduced |
| Point72 Asset Management, L.P. | 111,993 | $330.0K | 0.00% | −4,988−4.3% | Reduced |
| Falcon Edge Capital, LP | 121,193 | $347.0K | 0.04% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 128,335 | $379.0K | 0.10% | −10,997−7.9% | Reduced |
| Artal Group S.A. | 200,000 | $590.0K | 0.03% | 00.0% | Unchanged |
| AXA S.A. | 227,473 | $671.0K | 0.00% | −4,413−1.9% | Reduced |
| Nantahala Capital Management, LLC | 322,980 | $953.0K | 0.08% | −11,184−3.3% | Reduced |
| Nicholas Investment Partners, LP | 450,556 | $1.29M | 0.12% | −73,364−14.0% | Reduced |
| Redmile Group, LLC | 2,816,196 | $8.05M | 0.31% | 00.0% | Unchanged |
| Novo Holdings A/S | 3,327,312 | $9.82M | 0.48% | 00.0% | Unchanged |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −631−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −101−100.0% | Sold out |